about
Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in CancerThe transcription coactivator ASC-1 is a regulator of skeletal myogenesis, and its deficiency causes a novel form of congenital muscle diseaseThe Muscular Dystrophy Gene TMEM5 Encodes a Ribitol β1,4-Xylosyltransferase Required for the Functional Glycosylation of Dystroglycan.The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan additionCompound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy-dystroglycanopathy C1.Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy.An evaluation of the evolution of the gene structure of dystroglycanDiscovery of a nucleocytoplasmic O-mannose glycoproteome in yeast.ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan.Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathyExpression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycanThe extracellular matrix compartment of neural stem and glial progenitor cells.Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencingWhat Have We Learned from Glycosyltransferase Knockouts in Mice?Molecular Functions of Glycoconjugates in Autophagy.AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression.Distinctive MS/MS Fragmentation Pathways of Glycopeptide-Generated Oxonium Ions Provide Evidence of the Glycan Structure.Biological roles of glycans.Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.Myopathology in the times of modern genetics.Dolichol phosphate mannose synthase: a Glycosyltransferase with Unity in molecular diversities.Protein O-mannosylation is crucial for human mesencyhmal stem cells fate.Mouse models of human ocular disease for translational research.Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx.The evolution of the dystroglycan complex, a major mediator of muscle integrity.Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene.Genetic and Clinical Advances of Congenital Muscular Dystrophy.Structural and functional studies of differentially O-glycosylated analogs of a thrombin inhibitory peptide - variegin.Epigenetic regulation of neural N-glycomics.Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.Impairment of photoreceptor ribbon synapses in a novel Pomt1 conditional knockout mouse model of dystroglycanopathy.A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies
P2860
Q26748089-0943C37E-2F7B-465E-9310-8E12CFCEC6C1Q28508101-3D20B25C-0709-404C-AEE3-34DF9AE45EDDQ32884430-D68EF1A6-144F-4B0A-91D2-241E32F80CF8Q32884479-ADEC4C34-68A6-4B9A-924D-2F42BD97E0EDQ33844672-3FE73437-F03C-4DDF-863B-BADF887883BAQ35709549-3ABB74D0-079D-45B7-9736-46B2426069C8Q36241448-7CCB78C4-C41C-445B-AA33-9097D775BC98Q36419771-3B8A08A7-29A4-4B2E-9980-588B5DC94F21Q36919737-FAE1AB23-2B9C-44DB-8F58-99EBFE445246Q36960788-8B3594E8-B8E7-4666-AF2B-DDE40259699DQ37015841-A223A9F2-6284-46AF-90C1-036C9D08872AQ37200133-38CFF2AC-06BA-47DC-8A37-9129FA7EF504Q38443193-5274BCA1-31B0-4855-A4FD-4C5155BBAB85Q38647928-9CD8B752-6F2B-4F12-BC86-F784FBBE56F2Q38796983-1E1E3A3A-CC15-45EE-AFCF-76F4E3F017DBQ38848374-3361B2BB-42FD-42BE-8645-C1198A18D72FQ38882219-9CAEB8E1-E368-4723-B69D-1AAF98833DEEQ38932357-5D964A0E-EFE9-419B-9CD6-F7628362A8D4Q38936714-92416130-982F-4805-BB23-465363C78390Q39010745-3186F376-EABF-4F27-B563-E16F2B37E395Q39012279-683BF4DA-CD77-480C-AC43-63025692D2F1Q39051467-52DEB1B6-CB09-4202-AAEA-D16A24BA144AQ39375147-5C39772E-EA36-4634-B767-919D09C71E5BQ40657565-F8C6A90E-9335-4442-AAA4-C325161831EFQ41577738-1BC5D073-2BDD-414C-B7C8-C9BB8835E1FEQ41642554-3079D659-C6EF-4F17-8EA4-6267C75B9C54Q41820882-24D24AEF-5229-4F12-8446-2270AF49D039Q45835449-9FB80CE2-BBED-44F6-BF20-07F8AB3BBDF4Q46563168-4C73419D-D9D3-43AB-BCF8-69B183A74869Q47374895-E46E148A-28F5-4A1E-90B5-B0A4528276AAQ48684687-32E531CA-B6B3-43D0-82BC-14E4A941467AQ49685437-845FB9BF-20E5-475B-8285-30336F6C0829Q54957953-F493FA3B-A398-4A04-A4F8-8E2CB6EDE7B6Q59134959-0E9D0954-8CF8-4844-80C6-030B4454C39E
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Glycobiology of α-dystroglycan and muscular dystrophy.
@en
type
label
Glycobiology of α-dystroglycan and muscular dystrophy.
@en
prefLabel
Glycobiology of α-dystroglycan and muscular dystrophy.
@en
P2860
P356
P1476
Glycobiology of α-dystroglycan and muscular dystrophy.
@en
P2093
Tamao Endo
P2860
P356
10.1093/JB/MVU066
P577
2014-11-07T00:00:00Z